| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/05/2014 | CA2677703C Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor |
| 08/05/2014 | CA2554040C Use of meloxicam for the treatment of respiratory diseases in pigs |
| 08/05/2014 | CA2553886C Combined use of prame inhibitors and hdac inhibitors |
| 08/05/2014 | CA2521839C Augmented cognitive training |
| 08/05/2014 | CA2457140C Beta-amyloid-analogue - t-cell epitope vaccine |
| 07/31/2014 | WO2014117089A1 Compositions and methods for the treatment of pervasive development disorders |
| 07/31/2014 | WO2014114627A1 Combinations with 2-aminoethanesulfonic acid |
| 07/31/2014 | WO2014078446A3 Skin wound healing and scar reduction with prostaglandin ep4 agonist combinations |
| 07/31/2014 | US20140213990 Compositions and methods for treating surface wounds |
| 07/31/2014 | US20140213657 Lysine specific demethylase-1 inhibitors and their use |
| 07/31/2014 | US20140213649 Stabilized formulation comprising omega-3 fatty acids and use of the fatty acids for skin care and/or wound care |
| 07/31/2014 | US20140213621 Method for treatment of chronic neuropathic pain |
| 07/31/2014 | US20140213604 Protein kinase c as a target for the treatment of respiratory syncytial virus |
| 07/31/2014 | US20140213576 Novel compound useful for the treatment of degenerative and inflammatory diseases |
| 07/31/2014 | US20140213574 Heteroaryl compounds and uses thereof |
| 07/31/2014 | US20140213571 Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases |
| 07/31/2014 | US20140213563 Methods of diagnosing and treating neonatal reversion to fetal consciousness |
| 07/31/2014 | US20140213562 Medicinal cosmetic lipoatrophy |
| 07/31/2014 | US20140213560 Methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast n-oxide |
| 07/31/2014 | US20140213556 Compositions and methods for combination antiviral therapy |
| 07/31/2014 | US20140213553 Carbamoylpyridone derivatives |
| 07/31/2014 | US20140213552 Cyclohexylamines |
| 07/31/2014 | US20140213534 Intestinal hyperpermeability and prevention of systemic disease |
| 07/31/2014 | US20140213532 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 07/31/2014 | US20140213513 Exendin-4 Derivatives as dual GLP1/GIP or trigonal GLP1/GIP/Glucagon Agonists |
| 07/31/2014 | US20140213506 Thymosin alpha peptide for preventing, reducing the severity of, and treating infection |
| 07/31/2014 | US20140212969 Nucleic Acids, Polypetides, and Methods for Modulating Apoptosis |
| 07/31/2014 | US20140212572 Pharmaceutical compositions for the coordinated delivery of nsaids |
| 07/31/2014 | US20140212515 Composition and methods for optimizing health of cancer patients by the administration of sodium selenite and vitamin k3 |
| 07/31/2014 | US20140212514 Prevention of gastric ulcer by carbon monoxide |
| 07/31/2014 | US20140212509 Inhibitors of poly(adp-ribose)polymerase |
| 07/31/2014 | US20140212506 Method to Suppress the Systemic Toxicity of Chemotherapeutic Drugs |
| 07/31/2014 | US20140212504 Phospholipid-based powders for drug delivery |
| 07/31/2014 | US20140212492 Oral Enzyme Compositions for Intestinal Delivery |
| 07/31/2014 | US20140212489 Pharmaceutical compositions for the coordinated delivery of nsaids |
| 07/31/2014 | US20140212486 Isometheptene isomer |
| 07/31/2014 | US20140212484 Multilayered polyelectrolyte-based capsules for cell encapsulation and delivery of therapeutic compositions |
| 07/31/2014 | US20140212482 Multi-phase, multi-compartment, capsular delivery apparatus and methods for using same |
| 07/31/2014 | US20140212475 Anti-cancer compositions and methods |
| 07/31/2014 | US20140212448 Klebsiella antigens |
| 07/31/2014 | US20140212445 Use of modified cells for the treatment of multiple sclerosis |
| 07/31/2014 | US20140212434 Multivalent vaccines for rabies virus and filoviruses |
| 07/31/2014 | US20140212431 Pcsk9-binding polypeptides and methods of use |
| 07/31/2014 | US20140212425 Therapeutic use of anti-cd22 antibodies for inducing trogocytosis |
| 07/31/2014 | US20140212413 Methods of Treating TNF-alpha-Mediated Diseases Using Chimeric TNF-alpha Antibodies |
| 07/31/2014 | US20140212403 Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria |
| 07/31/2014 | US20140212396 Compositions and methods for treatment of cancer using bacteria |
| 07/31/2014 | US20140212386 Anti-tumor composition |
| 07/31/2014 | US20140212384 Therapeutic Methods |
| 07/31/2014 | US20140212382 Purine monophosphate prodrugs for treatment of viral infections |
| 07/31/2014 | US20140212379 Il-1 binding proteins |
| 07/31/2014 | US20140212370 Poly(urea-urethane) compositions useful as topical medicaments and methods of using the same |
| 07/31/2014 | US20140212362 Composition and method for treatment of symptoms associated with various skin conditions |
| 07/30/2014 | EP2758055A1 Combination treatments comprising c-met antagonists and b-raf antagonists |
| 07/30/2014 | EP2758053A1 Sodium channel blockers reduce glucagon secretion |
| 07/30/2014 | CN103959068A 基于纤溶酶原激活物抑制剂－1的流产、早产治疗药 Based on plasminogen activator inhibitor-1 miscarriage, premature therapeutic drugs |
| 07/30/2014 | CN103958679A 变异型α-辅肌动蛋白-4的抗体 Variant α- actinin-4 antibody |
| 07/30/2014 | CN103957930A 癌症治疗用疫苗制剂 Vaccine formulation for cancer treatment |
| 07/30/2014 | CN103951766A 聚合物、光响应胶束、光响应载药胶束及其制备方法 Polymer optical response micelles, light response micelles and its preparation method |
| 07/30/2014 | CN103948930A 一种含有赤芍和β-内酰胺类抗菌药的畜禽用复方药物 TPG and poultry containing β- lactam antibiotic compound drug use |
| 07/30/2014 | CN103948929A 骨科手术用防粘连粉雾剂及其制备方法 Orthopedic surgical adhesion prevention and preparation methods of inhalation |
| 07/30/2014 | CN103948928A 一种口服液和舌下喷剂及其制备方法 One kind of oral and sublingual sprays and preparation method |
| 07/30/2014 | CN103948927A 在癌症化疗和放疗时保护细胞的局部血管收缩剂制品和方法 Protection of cells in cancer chemotherapy and radiotherapy topical vasoconstrictor articles and methods |
| 07/30/2014 | CN103948926A miR-9抑制剂在制备用于抑制肿瘤生长药物中的用途 miR-9 inhibitor in the manufacture of a medicament for the inhibition of tumor growth in the use of |
| 07/30/2014 | CN103948922A 核仁蛋白抑制剂的医药用途 Medical use nucleolar protein inhibitors |
| 07/30/2014 | CN103948568A 一种静电喷雾技术制备载疏水性药物核壳结构微/纳米粒的方法 An electrostatic spray technique for preparing core-shell structure of a hydrophobic drug carrier micro / nanoparticles methods |
| 07/30/2014 | CN103948546A 一种包覆抗氧化剂的聚合物纳米囊泡的制备方法 Method for preparing a polymer-coated antioxidants nanovesicles |
| 07/30/2014 | CN103948542A 可逆转肿瘤多药耐药的中西药微乳共传递系统、其制备方法及其在制备抗肿瘤药物中的应用 Can reverse multidrug resistance in western microemulsion co-delivery system, their preparation and their antineoplastic application in preparation |
| 07/30/2014 | CN103030140B 透明质酸修饰的氧化石墨烯及其药物组合物的制备方法与应用 Preparation of hyaluronic acid-modified graphite oxide and pharmaceutical compositions and Application |
| 07/30/2014 | CN102688499B 白蛋白—聚乙二醇—药物分子偶联物 Albumin - polyethylene glycol - a drug molecule conjugates |
| 07/30/2014 | CN102526706B 牙周病和牙髓疾病的治疗剂以及治疗方法 The therapeutic agent of the disease and periodontal disease, and dental pulp treatments |
| 07/30/2014 | CN102292069B 囊泡制剂 Vesicle preparation |
| 07/30/2014 | CN102170873B 用于治疗与hedgehog通路有关的病症的smoothened拮抗 Hedgehog pathway for the treatment of disorders associated smoothened antagonist |
| 07/30/2014 | CN101921347B 透明质酸衍生物及含有其的药剂 Hyaluronic acid derivatives and their pharmaceutical agent containing |
| 07/30/2014 | CN101883561B 用于治疗cmt和相关疾病的新治疗方法 Treatment cmt and related diseases for new treatment |
| 07/29/2014 | US8791263 Cortistatin A analog and use thereof |
| 07/29/2014 | US8791159 Compound capable of binding S1P receptor and pharmaceutical use thereof |
| 07/29/2014 | US8791114 Dihydropyrazoles |
| 07/29/2014 | US8791091 Aryl dihydropyridinone and piperidinone MGAT2 inhibitors |
| 07/29/2014 | US8791079 Methods for treating heart failure by inhibiting the mitochondrial sodium-calcium exchanger (mNCE) |
| 07/29/2014 | US8791078 Cell protection in dialysis patients by administration of a creatine compound |
| 07/29/2014 | US8790724 Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care |
| 07/29/2014 | US8790700 Modified release formulations containing drug-ion exchange resin complexes |
| 07/29/2014 | US8790655 Conjugates of synthetic TLR agonists and uses therefor |
| 07/29/2014 | US8790649 EGFR-binding molecules and immunoconjugates thereof |
| 07/29/2014 | CA2697205C Peptidomimetic protease inhibitors |
| 07/29/2014 | CA2483451C Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance |
| 07/24/2014 | WO2014113794A2 Oligooxopiperazines for p53 reactivation |
| 07/24/2014 | WO2014113729A2 Methods of treating cholangiocarcinoma |
| 07/24/2014 | WO2014113260A1 Androgen receptor modulator and uses thereof |
| 07/24/2014 | WO2014111580A1 Urolithin b for muscle growth |
| 07/24/2014 | WO2014083567A3 Methods of preventing tumor metastasis, treating and prognosing cancer and identifying agents which are putative metastasis inhibitors |
| 07/24/2014 | WO2014083019A3 Agent for modulating the dissemination of cancer cells, product comprising said agent, and use of said agent in the treatment and/or prevention of cancer |
| 07/24/2014 | US20140206762 Compositions And Methods Of Use Of Phorbol Esters |
| 07/24/2014 | US20140206757 Treatment of cancer |
| 07/24/2014 | US20140206745 Methods for modulating kallikrein (klkb1) expression |
| 07/24/2014 | US20140206740 Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters |
| 07/24/2014 | US20140206724 Methods for treating non-hodgkin's lymphoma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with a second active agent |
| 07/24/2014 | US20140206723 Methods for treating amyloidosis with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione |
| 07/24/2014 | US20140206708 Composition for ophthalmic administration |